EFTRW Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 Jun 2024 @ 11:06):
Our systems believe the stock currently is undervalued by 0.94% compare to its pairs and should correct upwards.

eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer...

Stats
Today's Volume	97 702
Average Volume	0
Market Cap	641 019
EPS	$-2.16 ( Q1 \| 2024-05-09 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0 (Sector) 42.63 (Industry) 24.32
ATR14	$0 (0.00%)

AADI -3.53%

ABCL 1.83%

ABCM 0.04%

ABEO -2.13%

ABIO -2.23%

ABOS 0.00%

ABSI 1.70%

ABUS -2.30%

ABVX -2.03%

ACAD -0.58%

ACER -17.95%

ACET -5.42%

ACGN 1.29%

ACHL -2.22%

ACHV -1.29%

ACIU -1.75%

ACLX 0.09%

ACRV -5.61%

ACST -3.58%

ACXP 1.38%

ADAG 4.64%

ADAP -4.26%

ADGI 0.87%

ADIL 0.54%

ADMA -2.77%

ADPT -0.15%

ADTX -3.47%

ADVM -3.33%

ADXN -1.60%

AEON -3.74%

AEZS -2.51%

AFMD -0.61%

AGEN -3.03%

AGIO -2.29%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA -2.28%

AKRO -2.57%

AKTX 4.08%

AKUS 0.00%

ALBO 0.00%

ALDX -2.40%

ALEC -1.83%

ALGS -1.82%

ALKS -0.19%

ALLK -9.31%

ALLO -4.79%

ALLR -3.37%

ALNA 3.16%

ALNY 2.26%

ALPN 0.02%

ALPX 0.00%

ALRN 0.33%

ALT -9.31%

ALVR -0.40%

ALXN 0.00%

ALXO -11.19%

ALZN 2.04%

AMRN -0.72%

AMTI -3.13%

ANAB 1.05%

ANEB -1.52%

ANGN 0.00%

ANIX -1.62%

ANL -6.60%

ANNX -1.53%

ANPC -3.15%

APGE -1.12%

APGN 8.48%

APGNW 30.65%

APLM -5.01%

APLS 0.25%

APLT -3.72%

APM -2.94%

APOP 0.38%

APRE 0.61%

APTO 6.30%

APTX 3.17%

APVO 0.18%

ARAV -13.39%

ARCT -4.61%

ARDS -14.23%

ARDX -0.58%

ARGX -1.08%

ARNA 0.00%

ARPO -0.90%

ARQT -1.41%

ARTL -2.50%

ARTLW 0.00%

ARVN 6.02%

ARWR -1.67%

ASLN -5.07%

ASMB -5.83%

ASND -1.45%

ATAI -1.11%

ATHA 5.48%

ATHE 0.55%

ATHX -33.50%

ATNF 0.99%

ATOS 0.97%

ATRA -2.83%

ATXI 1.93%

ATXS -0.67%

AUPH -0.99%

AURA 1.17%

AUTL -2.01%

AVBP -4.23%

AVEO 0.00%

AVIR -0.44%

AVRO -1.41%

AVTE -4.88%

AVTX -1.25%

AVXL -2.96%

AXLA 0.00%

AXSM -1.73%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 1.45%

BCAB 2.60%

BCDA -2.73%

BCDAW -41.77%

BCEL 0.00%

BCLI 5.82%

BCRX 0.99%

BCTX 8.16%

BCTXW -17.41%

BCYC 0.50%

BDRX -4.94%

BDTX -0.85%

BEAM 0.79%

BFRA -2.91%

BGNE -2.99%

BIOR -3.80%

BIVI 4.22%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -0.89%

BLTE -0.62%

BLU 0.03%

BLUE -0.25%

BMEA -11.23%

BMRN 0.44%

BNOX -2.22%

BNTC -0.42%

BNTX -1.86%

BOLD -8.58%

BOLT 0.72%

BPMC -1.09%

BPTH 1.42%

BPTS -13.47%

BRNS -0.74%

BRTX -2.36%

BTAI 25.39%

BTTX 53.33%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 3.39%

CABA 0.90%

CADL -1.31%

CALA 0.00%

CALC -1.77%

CALT -1.14%

CAPR -2.80%

CARA -0.12%

CARM 10.35%

CASI -1.65%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS -6.50%

CCCC -5.31%

CCXI 0.00%

CDAK 0.00%

CDIO -2.20%

CDIOW 24.00%

CDMO -2.95%

CDMOP 0.04%

CDT -12.20%

CDTTW -39.60%

CDTX -1.92%

CDXC 0.41%

CDXS 7.28%

CELC -4.58%

CELU -1.97%

CELUW 11.80%

CERC -1.68%

CERE -1.04%

CERO -4.45%

CEROW -20.21%

CFRX -27.95%

CGEM -2.47%

CGEN -3.87%

CGON -1.56%

CGTX -4.54%

CHMA -6.00%

CHRS 0.32%

CINC 0.00%

CING 2.15%

CINGW 34.95%

CKPT -3.35%

CLBS -16.75%

CLDX -2.21%

CLGN 0.34%

CLLS -4.15%

CLNN 2.42%

CLNNW 0.00%

CLRB 7.41%

CLSD 0.00%

CLSN -0.68%

CLVS 0.00%

CMMB -0.98%

CMND 0.81%

CMPI 0.00%

CMPX -7.19%

CMRA 0.00%

CMRAW 33.33%

CMRX -3.04%

CNCE 0.00%

CNSP -37.41%

CNST 0.00%

CNTA -0.67%

CNTB 0.00%

CNTX -6.85%

COCP -2.00%

COEPW 32.45%

COGT -2.40%

CORT 2.04%

COYA -1.46%

CPRX -1.22%

CRBP -3.34%

CRBU -4.83%

CRDF -1.33%

CRGX 0.47%

CRIS -0.38%

CRNX -5.89%

CRSP 1.22%

CRTX 2.63%

CRVO -2.50%

CRVS 1.82%

CSBR -1.59%

CTCX -1.60%

CTIC 0.06%

CTMX -2.89%

CTNM -0.85%

CTXR 2.01%

CUE 3.78%

CVAC -2.54%

CVKD 0.11%

CWBR 2.80%

CYAD -12.96%

CYCC 9.03%

CYCCP 5.49%

CYCN 0.43%

CYT -2.27%

CYTK -1.82%

CYTO -1.82%

DARE 6.33%

DAWN 0.30%

DBTX -0.81%

DBVT 4.17%

DFFN 10.28%

DICE 0.06%

DMAC 26.99%

DNLI -1.70%

DNTH -8.81%

DOMH -1.58%

DRMA -1.10%

DRMAW -1.25%

DRNA 0.00%

DRTS 1.85%

DRTSW 0.00%

DRUG 0.95%

DSGN -1.51%

DTIL 0.56%

DYAI 10.32%

EARS -1.77%

EDIT -3.02%

EDSA 3.19%

EFTR 4.55%

EFTRW -51.85%

EIGR -9.21%

ELAB -1.00%

ELDN 7.56%

ELEV -5.81%

ELOX 7.69%

ELTX -0.88%

ELVN -4.45%

ELYM 2.30%

ENGN -4.44%

ENGNW 0.12%

ENLV 2.54%

ENOB 1.79%

ENSC 4.17%

ENTA -0.57%

ENTO -2.47%

ENTX 2.08%

ENVB -0.84%

EPIX -0.31%

EPRX -2.97%

EPZM 0.00%

EQ 0.32%

EQRX -2.09%

EQRXW 0.00%

ERAS -1.20%

ERNA 0.00%

ERYP 1.30%

ESLA 4.30%

ESLAW 87.05%

ETNB -0.76%

ETON 2.13%

ETTX 0.00%

EVAX -2.14%

EVGN 3.97%

EVLO 0.00%

EWTX 0.03%

EXAI -0.38%

EXEL -0.31%

EYEG -0.69%

EYEN 0.43%

EYPT 0.06%

FATE -8.06%

FBIO 0.89%

FBIOP 0.92%

FBLG -16.61%

FBRX -0.04%

FDMT -4.18%

FENC -1.29%

FGEN -5.93%

FHTX 1.71%

FIXX 0.77%

FMTX 0.00%

FNCH 8.87%

FOLD -2.63%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE 0.02%

FULC -3.85%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -6.73%

GANX -2.31%

GBIO -2.12%

GBT 0.01%

GDTC 0.50%

GERN -4.20%

GHRS -2.16%

GLMD -2.33%

GLPG -2.26%

GLSI 1.69%

GLTO -0.57%

GLUE -2.50%

GLYC -9.70%

GMAB -0.50%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -0.91%

GNLX 1.10%

GNPX 0.98%

GNTA 3.94%

GOSS -10.46%

GOVX 4.54%

GOVXW -49.04%

GPCR -6.73%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS 0.03%

GRTX 2.57%

GTHX 0.45%

GUTS -5.54%

GXGXW 41.67%

GYRE -7.16%

HALO -1.33%

HARP 0.09%

HCWB -3.75%

HEPA 2.80%

HGEN -84.62%

HILS 5.66%

HLVX -0.46%

HOOK -0.02%

HOTH -2.70%

HOWL -2.14%

HRMY 0.66%

HRTX 3.44%

HSTO 0.00%

HUMA 0.61%

HUMAW -0.01%

IBRX -4.33%

ICCC 0.22%

ICPT 0.21%

ICU 15.94%

ICUCW 20.20%

ICVX -0.91%

IDRA -23.04%

IDYA -1.61%

IFRX -1.85%

IGMS -0.44%

IKNA 1.19%

IKT 1.42%

IMAB -0.29%

IMCR -3.36%

IMGN 0.02%

IMGO 0.00%

IMMP 5.70%

IMMX -7.33%

IMNM -1.86%

IMNN 0.88%

IMPL -27.27%

IMRA 15.96%

IMRN -1.18%

IMRX -0.35%

IMTX -1.67%

IMTXW 6.00%

IMUX 1.56%

IMV 0.00%

IMVT -3.85%

INAB 0.00%

INBX 0.53%

INCY -0.89%

INDP 11.07%

INFI -52.38%

INKT -0.01%

INM 3.30%

INMB 2.66%

INO -2.47%

INSM -1.30%

INTS -2.75%

INVA 0.31%

INZY 0.69%

IOBT -12.55%

IONS 0.21%

IOVA -2.37%

IPA 2.50%

IPHA 5.58%

IPSC -1.96%

IRON -2.52%

ISEE 0.38%

ITOS -1.90%

ITRM 1.67%

IVA 6.96%

IVVD -2.47%

JAGX 1.05%

JANX -4.12%

JAZZ -0.69%

JNCE 0.00%

JSPR -6.20%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -3.54%

KALV -1.99%

KDNY 0.22%

KMPH -0.34%

KNSA -2.90%

KNTE -0.38%

KOD -6.93%

KPRX 0.96%

KPTI -1.38%

KRBP -10.00%

KRON 1.05%

KROS -1.38%

KRRO -8.23%

KRTX 0.03%

KRYS -1.16%

KTRA 16.09%

KTTA 8.16%

KTTAW 0.92%

KURA -1.51%

KYMR -2.60%

KYTX -4.33%

KZIA 2.65%

KZR -0.93%

LABP 0.57%

LBPH -2.31%

LBPS 0.00%

LBPSW 14.81%

LEGN 1.82%

LENZ -3.73%

LEXX 1.16%

LEXXW -14.63%

LGND -1.30%

LGNDV 0.00%

LGVN -10.11%

LIAN -8.28%

LIFE 2.70%

LIPO -11.13%

LIXT -5.24%

LIXTW 63.57%

LJPC -0.32%

LMNL 0.12%

LOGC 1.48%

LPCN -2.95%

LPTX -1.65%

LQDA -0.90%

LRMR -2.20%

LSTA -4.06%

LTRN 1.37%

LUMO -1.32%

LVTX -1.01%

LXEO -4.21%

LXRX -2.06%

LYEL -33.58%

LYRA 1.16%

MACK 0.10%

MBIO -10.90%

MBRX -2.57%

MCRB 2.56%

MDGL -3.53%

MDNA -13.16%

MDWD -0.27%

MDXG -2.58%

MEIP -0.13%

MESO -2.08%

MGNX -3.03%

MGTA -7.74%

MGTX -3.56%

MGX 0.54%

MIRM -1.90%

MIRO 0.59%

MIST 0.76%

MITO 0.00%

MLEC -7.69%

MLECW 2.31%

MLND -5.36%

MLTX -0.57%

MLYS -7.15%

MNKD -1.34%

MNMD 0.35%

MNOV 2.11%

MNPR -5.01%

MOLN 0.28%

MOR 1.29%

MORF -2.79%

MREO -4.57%

MRKR 2.68%

MRNA -5.04%

MRNS -4.04%

MRSN -1.90%

MRTX -0.17%

MRUS 0.22%

MRVI -1.82%

MTCR -1.29%

MTEM 4.95%

MTP -18.50%

MURA -0.93%

MYMD 5.41%

NAMS 2.03%

NAMSW 0.43%

NAUT 1.55%

NBRV 0.71%

NBSE -1.56%

NBTX 8.61%

NCNA 1.82%

NERV -0.63%

NEXI 4.04%

NGM -1.28%

NGNE -1.93%

NKGN 10.62%

NKGNW 8.00%

NKTR -4.19%

NKTX -4.74%

NLSP 7.48%

NLSPW 26.67%

NMRA -3.33%

NMTR -42.97%

NOVN -24.84%

NRBO 9.15%

NRIX -0.34%

NRSN -6.31%

NRSNW 0.00%

NRXP -4.32%

NRXPW 18.33%

NRXS 4.82%

NTBL 5.06%

NTEC -12.45%

NTHI 0.00%

NTLA -5.54%

NTRBW -31.07%

NUVL -1.72%

NVAX -2.27%

NVCT 2.38%

NVIV -34.28%

NXTC -2.94%

NYMX -0.05%

OABI 0.00%

OABIW -10.06%

OBIO -3.36%

OBSV 0.00%

OCEA 0.00%

OCGN 3.81%

OCS -1.00%

OCUL -1.83%

OCUP 1.31%

ODT -4.27%

OKYO 1.51%

OLMA -6.14%

OMER -0.51%

OMGA 5.00%

ONCO 4.96%

ONCR -3.08%

ONCS 31.87%

ONCT -3.05%

ONCY -0.99%

ONTX -0.47%

ONVO 0.99%

OPNT 0.00%

OPT 2.06%

ORGS 0.67%

ORIC -3.41%

ORMP 21.16%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -2.36%

OVID -1.44%

OYST 0.00%

PALI 2.58%

PASG -1.30%

PBLA -7.50%

PBM -4.89%

PBYI 1.35%

PCSA 0.00%

PCVX -0.59%

PDSB -3.80%

PEPG 1.12%

PGEN -2.99%

PHAR 1.51%

PHAS 0.00%

PHAT -1.40%

PHIO -3.57%

PHIOW 36.47%

PHVS -6.81%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -1.37%

PLUR 7.49%

PMN 0.72%

PMVP 0.00%

PNT 0.16%

PPBT -10.64%

PRAX 0.59%

PRDS 0.93%

PRLD -3.17%

PROG -3.47%

PROK -0.45%

PRQR -0.61%

PRTA -2.74%

PRTC 0.49%

PRTG -0.54%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -6.18%

PSTX -1.16%

PTCT -0.54%

PTE -0.82%

PTGX -1.80%

PTIXW -49.04%

PULM 2.60%

PXMD 0.00%

PYPD 0.07%

PYXS 1.63%

QLGN -4.39%

QNCX 5.70%

QNRX 0.37%

QSI -11.36%

QSIAW -3.13%

QTTB -1.83%

QURE -0.84%

RAIN -1.63%

RANI 6.42%

RAPT -3.57%

RARE 1.20%

RCKT -7.97%

REGN -0.31%

RENB -3.11%

REPL -2.95%

RETA 0.02%

REUN -0.89%

REVB -1.40%

REVBU 3.46%

REVBW 4.38%

RGLS -5.37%

RGNX -5.93%

RIGL -3.29%

RLAY -3.86%

RLMD 0.33%

RLYB -0.34%

RNA -0.10%

RNAC -5.94%

RNAZ -0.96%

RNXT 1.88%

ROIV -2.17%

ROIVW 4.56%

RPHM -0.31%

RPRX 0.19%

RPTX -2.35%

RUBY 2.70%

RVLP -32.05%

RVMD -1.09%

RVMDW -30.00%

RVNC 2.34%

RVPH -1.61%

RVPHW 1.62%

RXDX 0.09%

RXRX -3.52%

RYTM -6.74%

RYZB 0.02%

RZLT 0.77%

SABS -1.37%

SABSW -11.81%

SAGE 1.74%

SANA -3.97%

SAVA -0.47%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 5.50%

SCPH 2.40%

SCPS 0.00%

SEEL -3.63%

SEER 0.59%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -0.13%

SGMT -2.41%

SGTX -2.56%

SIOX 22.63%

SLDB -5.69%

SLGL 2.97%

SLN -4.76%

SLNO -4.03%

SLRX 6.07%

SLS -2.15%

SMMT -2.75%

SNDX 1.43%

SNGX -3.40%

SNPX -3.73%

SONN -1.08%

SPPI -0.49%

SPRB 1.52%

SPRC -2.75%

SPRO 0.05%

SRNE -34.00%

SRPT -1.30%

SRRA 0.00%

SRRK -2.35%

SRZN -2.45%

STAB 0.00%

STOK -5.38%

STRO -3.01%

STSA 0.00%

STTK -2.67%

SURF -0.93%

SVRA -4.60%

SWTX 0.16%

SYBX -1.94%

SYRS -1.03%

TALS -0.73%

TARA -8.10%

TARS -0.56%

TBPH 0.60%

TCBP 2.47%

TCDA 0.00%

TCON 0.68%

TCRR 0.00%

TCRT 1.59%

TCRX 1.45%

TECH -0.08%

TENX -1.27%

TERN -7.73%

TFFP -5.33%

TGTX -3.23%

THRX 0.12%

TIL -1.09%

TLC 0.00%

TLSA -2.11%

TNGX -2.91%

TNXP -4.81%

TNYA -6.83%

TPST 3.40%

TRDA -4.64%

TRVI 2.30%

TRVN 2.97%

TSHA -24.34%

TSVT -2.93%

TTNP -7.79%

TVTX 0.50%

TYRA -7.54%

UBX -0.72%

UNCY -3.90%

URGN -1.51%

UTHR -0.37%

VACC 11.36%

VALN -2.89%

VAXX 83.69%

VBIV 0.78%

VBLT -8.77%

VCEL -0.16%

VCNX 10.35%

VCYT -1.01%

VERA -3.80%

VERU -0.57%

VERV -2.78%

VIGL 7.53%

VINC 2.96%

VIR 0.54%

VIRI -1.61%

VIRX 2.40%

VKTX -1.33%

VLON -13.04%

VNDA -2.61%

VOR -2.02%

VRCA 0.00%

VRDN -4.31%

VRNA -1.66%

VRPX 0.38%

VRTX 0.33%

VSTM -2.10%

VTGN -1.05%

VTVT -2.97%

VTYX -1.26%

VXRT -4.03%

VYGR -0.77%

VYNE -4.34%

VYNT 7.78%

WINT -3.24%

WVE -4.20%

XBIO 0.93%

XBIT -2.71%

XCUR 3.58%

XENE -2.82%

XERS 2.14%

XFOR 2.95%

XLO 4.54%

XLRN 0.00%

XNCR 0.36%

XOMA -2.94%

XOMAO 0.36%

XOMAP -0.82%

XRTX -8.00%

YMAB -1.96%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -2.83%

ZNTL -0.83%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2023-11-27	Sr One Capital Management, Llc	Sell	430 578	Common Stock
2023-11-27	Sr One Capital Management, Llc	Sell	178 585	Common Stock
2023-11-15	Worland Stephen T	Buy	5 979	Common Stock
2023-11-15	Byrnes Michael	Buy	4 524	Common Stock
2023-09-09	Loewy Caroline M	Buy	40 000	Stock Option (Right to Buy)

INSIDER POWER
28.90
Last 94 transactions
Buy: 4 047 347 \| Sell: 1 063 888

Correlation (AI algo v.1.1b): Undervalued: 0.94% $0.00131 paired level. (The Algo Track The Changes Of The Most Correlated Stocks In Realtime And Give An Instant Update)

eFFECTOR Therapeutics, Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

eFFECTOR Therapeutics, Financials

Annual	2023
Revenue:	$0
Gross Profit:	$-111 000 (0.00 %)
EPS:	$-16.37

FY	2023
Revenue:	$0
Gross Profit:	$-111 000 (0.00 %)
EPS:	$-16.37

FY	2022
Revenue:	$3.55M
Gross Profit:	$3.50M (98.51 %)
EPS:	$-7.85

FY	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$0

Financial Reports:

No articles found.

eFFECTOR Therapeutics, Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

eFFECTOR Therapeutics,

eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer. Its lead product candidate is Tomivosertib, an oral small-molecule inhibitor of MNK that is in phase 2b clinical trial for the treatment of patients with metastatic non-small cell lung cancer. The company is also developing zotatifin, a small molecule designed to inhibit eukaryotic initiation factor 4A (eIF4E), which is in Phase 1/2 clinical trial to treat patients with solid tumors and in combination with fulvestrant and abemaciclib in a Phase 2a open-label expansion cohort to treat patients with ER+ breast cancer. eFFECTOR Therapeutics, Inc. has a research collaboration and license agreement with Pfizer Inc. to develop inhibitors of eIF4E. eFFECTOR Therapeutics, Inc. was incorporated in 2012 and is headquartered in Solana Beach, California.